173 related articles for article (PubMed ID: 34036681)
1. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening.
Li B; Guo R; Lai T; Qiao L; Fu H
J Obstet Gynaecol Res; 2021 Aug; 47(8):2720-2728. PubMed ID: 34036681
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
3. Letter to "The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening".
Domenici L
J Obstet Gynaecol Res; 2021 Sep; 47(9):3419-3420. PubMed ID: 34155727
[No Abstract] [Full Text] [Related]
4. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
Fan Y; Shen Z
Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
[TBL] [Abstract][Full Text] [Related]
6. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
8. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
9. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
Liu J; Yang T; Hu Y; Ye C
J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
[TBL] [Abstract][Full Text] [Related]
10. The effect of high-risk HPV E6/E7 mRNA on the efficacy of topical photodynamic therapy with 5-aminolevulinic acid for cervical high-grade squamous intraepithelial lesions.
Zhang T; Zhang Y; Tang Y; Qin L; Shen Y; Wang B; Zhang L; Cao L; Zhou Y; Su Y; Wang L; Zhang M
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102974. PubMed ID: 35724936
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
12. Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Rong S; Okunieff P; Zhang L; Li X
J Virol Methods; 2015 Nov; 224():35-41. PubMed ID: 26297960
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
15. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
16. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
17. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
Coquillard G; Palao B; Patterson BK
Gynecol Oncol; 2011 Jan; 120(1):89-93. PubMed ID: 20950847
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.
Hui C; Bai H; Liu J; Lu X; Wang S; Zhang Z; Jin M; Wang Y; Liu Y
Diagn Pathol; 2021 Feb; 16(1):13. PubMed ID: 33608003
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
